AN2 Therapeutics, Inc. (ANTX) vs Journey Medical Corporation (DERM)
A side-by-side comparison of AN2 Therapeutics, Inc. and Journey Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANTX
AN2 Therapeutics, Inc.
$5.21HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
DERM
Journey Medical Corporation
$6.50HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — ANTX vs DERM
growth of $100 · dividends reinvested · last 5yANTX -63.6% (-18.3%/yr)DERM +43.6% (+7.5%/yr)DERM compounded faster over this window
ANTX DERM
ANTX vs DERM: by the numbers
- •ANTX is the larger company ($188M vs $179M market cap).
- •Both run net losses; ANTX's is the smaller (0.00% vs -8.95% net margin).
Metrics side by side
Valuation
| Metric | ANTX | DERM |
|---|---|---|
| P/S ratio | N/A | 2.62 |
| P/B ratio | 2.47 | 5.57 |
| EV / EBITDA | N/A | 141.67 |
Profitability
| Metric | ANTX | DERM |
|---|---|---|
| Gross margin | 0.00% | 62.24% |
| Operating margin | 0.00% | -13.21% |
| Net margin | 0.00% | -8.95% |
| ROE | -47.78% | -19.01% |
| ROIC | -51.01% | -5.22% |
Growth (annualized)
| Metric | ANTX | DERM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.